Company involving high tech, life sciences and biotech

Austrianova is one company that does services that involves high tech, life sciences and biotech. It is combined with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science associated company that concentrate in the indusion of living cells or bacteria in little casings for protection which is also known as cell encapsulation technology, isolation, storage and transportation. We were first established in the year 2007 and was advanced in Singapore's best study biotech hub, Biopolis that has global footprint in supporting encapsulation packages like micro encapsulation.

There is a fast growing subject of attention in healthy repair and more exact, in the subject of neutraceuticals which is the knowing and use of probiotic bacteria. Hence, probiotics encapsulation was built. The cell-in-a-box technology was created by Austranova with the goal to keep safe, isolate, collect and transport living cells. This proprietary technology can be used for many purposes and can be used to probiotics, cosmetics and agriculture environmental protection and screening as well as creating the foundation of a powerful exploration device.

In healthcare, this knowledge helps controloperate harmless attaching of cells or stem cells such as cell therapy, combining them isolated from the immune system and permitting long stage production of therapeutic molecules in patients. In biotechnology, the cell-in-a-box procedure defends cells in bioreactors and fermentors and at the same time, it make simpler sanitization of bioproducts formed from the cells and it reduces production price too.

A large rule cGMP facility for the manufacturing of biomedical grade encapsulated cell tools was previously effectively established and right now, Austrianova is in the process of building this capability in the whole of SE Asia. This means the use of cell-in-a-box was quite a accomplishment for ancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to permit lower doses of chemotherapy to be used more productively without the normal devastating side consequences. The encapsulated cell are positioned, using supraselective catheterisation, into blood vessels that leads to the tumor where they locally switch a chemotherapeutic product to its tumor toxic product.

Visit our site for additional details: Encapsulation Technology, GMP Manufacturing , Micro Encapsulation.